AstraZeneca PLC (AZN)
Healthcare
- Headquarters
- United States
- Employees
- 96,100
- Market Cap
- $250.5B
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
SentiSense also tracks daily options readings for AstraZeneca PLC: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
AstraZeneca PLC stock analysis, sentiment tracking, and market intelligence on SentiSense.